Your browser doesn't support javascript.
loading
Efficacy and Safety of Leflunomide for Refractory COVID-19: A Pilot Study.
Wang, Qiang; Guo, Haipeng; Li, Yu; Jian, Xiangdong; Hou, Xinguo; Zhong, Ning; Fei, Jianchun; Su, Dezhen; Bian, Zhouyan; Zhang, Yi; Hu, Yingying; Sun, Yan; Yu, Xueyuan; Li, Yuan; Jiang, Bei; Li, Yan; Qin, Fengping; Wu, Yingying; Gao, Yanxia; Hu, Zhao.
Afiliación
  • Wang Q; Department of Nephrology, Qilu Hospital (Qingdao), Cheeloo College of Medicine, Shandong University, Qingdao, China.
  • Guo H; Department of Critical Care Medicine, Qilu Hospital, Cheeloo College of Medicine, Shandong University, Jinan, China.
  • Li Y; Department of Respirology, Qilu Hospital, Cheeloo College of Medicine, Shandong University, Jinan, China.
  • Jian X; Department of Emergency Medicine, Qilu Hospital, Cheeloo College of Medicine, Shandong University, Jinan, China.
  • Hou X; Department of Endocrinology, Qilu Hospital, Cheeloo College of Medicine, Shandong University, Jinan, China.
  • Zhong N; Department of Gastroenterology, Qilu Hospital, Cheeloo College of Medicine, Shandong University, Jinan, China.
  • Fei J; Department of Anesthesiology, Qilu Hospital, Cheeloo College of Medicine, Shandong University, Jinan, China.
  • Su D; Department of Psychiatry, Renmin Hospital of Wuhan University, Wuhan, China.
  • Bian Z; Department of Cardiology, Renmin Hospital of Wuhan University, Wuhan, China.
  • Zhang Y; Department of Respirology, Qilu Hospital, Cheeloo College of Medicine, Shandong University, Jinan, China.
  • Hu Y; Department of Quality Control, Qilu Hospital, Cheeloo College of Medicine, Shandong University, Jinan, China.
  • Sun Y; Department of Nephropathy, Shandong Provincial Third Hospital, Cheeloo College of Medicine, Shandong University, Jinan, China.
  • Yu X; Department of Nephropathy, Qilu Hospital, Cheeloo College of Medicine, Shandong University, Jinan, China.
  • Li Y; Department of Critical Care Medicine, Qilu Hospital, Cheeloo College of Medicine, Shandong University, Jinan, China.
  • Jiang B; Department of Nephropathy, Qilu Hospital, Cheeloo College of Medicine, Shandong University, Jinan, China.
  • Li Y; Department of Nephropathy, Qilu Hospital, Cheeloo College of Medicine, Shandong University, Jinan, China.
  • Qin F; Department of Nephropathy, Qilu Hospital, Cheeloo College of Medicine, Shandong University, Jinan, China.
  • Wu Y; Department of Nephropathy, Qilu Hospital, Cheeloo College of Medicine, Shandong University, Jinan, China.
  • Gao Y; Department of Nephrology, Qilu Hospital (Qingdao), Cheeloo College of Medicine, Shandong University, Qingdao, China.
  • Hu Z; Department of Nephropathy, Qilu Hospital, Cheeloo College of Medicine, Shandong University, Jinan, China.
Front Pharmacol ; 12: 581833, 2021.
Article en En | MEDLINE | ID: mdl-34276351
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Tipo de estudio: Clinical_trials Idioma: En Revista: Front Pharmacol Año: 2021 Tipo del documento: Article País de afiliación: China
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Tipo de estudio: Clinical_trials Idioma: En Revista: Front Pharmacol Año: 2021 Tipo del documento: Article País de afiliación: China